Let's talk medical research

November is COPD Awareness Month, a time that COPD patients, caregivers and organizations promote better COPD treatment and the need for research. Nearly 16 million people in the United States have been diagnosed with COPD, and it’s the third leading cause of death in the United States.

National Diabetes Awareness Month is a time to drive awareness of the disease – what it’s like to live with it, what’s the best way to treat it right now, and what research is happening that can give us a glimpse of the future of diabetes treatment and care.

Today is the first day of National Diabetes Awareness Month, and to mark the occasion, we had a conversation with three college students, Hannah, Julie, and Natali, who started their own chapter of the College Diabetes Network at the College of New Jersey.

We interviewed Alice Bast, CEO of Beyond Celiac, about her organization and what's next for celiac disease research.

It’s Mental Illness Awareness Week, a week dedicated to raising awareness of mental illness, which affects approximately 1 in 5 Americans in a given year.

What is Mild Cognitive Impairment? Mild cognitive impairment (MCI) causes slight but noticeable memory changes and thinking problems. These thinking problems are worse than those associated with normal aging, but not as severe as Alzheimer’s disease memory loss symptoms.

Though asthma is a condition that impacts an estimated 27 million Americans, the experience each individual has with it is unique. Depending on the type and severity, managing life with asthma can be a burden — especially if the treatments currently available are not particularly effective.

Our friends at Us Against Alzheimer’s recently announced that 27 Phase III and 8 Phase II Alzheimer’s disease drugs appear on track to launch in the next 5 years. While it remains to be seen which, if any, of these drugs will prove successful, the mere fact that so much Alzheimer’s research is being done is big news for a community made up of 5.4 million individuals who haven’t seen a novel ...

Living with rare diseases can be exceptionally challenging, and patients often must deal with years of misdiagnosis on their journey. A common refrain in the clinical trial recruitment industry is that patients are looking for trials and researchers are looking for patients — and nowhere is that truer than in the rare diseases community. Because rare diseases typically have limited treatment ...

One year ago, JDRF launched Antidote Match on the Clinical Trials Connection page. To mark the occasion, we sat down with our two main collaborators, Sydney Yovic, AVP of Research Operations and Mission, and Monica Harrington, Manager of Research Communications, to reflect on what we have learned over the last 12 months and to talk about the next steps for the partnership.